Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Sickle Cell Disease
100%
Acute Chest Syndrome
100%
Standard of Care
27%
Pediatric Sickle Cell Disease
27%
Inpatient Pediatrics
18%
Stakeholder Research
18%
Implementation Science
18%
Pediatric
18%
Healthcare Providers
18%
Health Practices
17%
Clinical Decision Support Systems
14%
Decision Support System
12%
Hybrid Effectiveness-implementation Study
11%
Opportunity Motivation
9%
Chronic Hemolytic Anemia
9%
Opportunity Model
9%
Guide Design
9%
Introductory Level
9%
Capability Model
9%
Epidemiology
9%
Childrens
9%
Advanced Statistical Methods
9%
Bronx
9%
Provider Attitudes
9%
Bioinformatics
9%
Career Goals
9%
Implementation Outcomes
9%
Behavioral Model
9%
Health Systems
9%
Motivation Model
9%
Poor Outcome
9%
Statistical Design
9%
Disease Groups
9%
Hematologist
9%
Service Science
9%
Clinical Expertise
9%
Department Chair
9%
United States
9%
Master of Science
9%
Pre-analysis Plan
9%
Albert Einstein
9%
Design Information
9%
Mentorship
9%
Electronic Health Records
9%
New York City
9%
Disease Management
9%
Implementation Method
9%
Research Independence
9%
Maintenance Framework
9%
College of Medicine
9%
Health Services Research/methods
9%
Adoption Framework
9%
User-centered Design Principles
9%
Effectiveness Framework
9%
Implementation Framework
9%
Shortened Lifespan
9%
Health Services Research
9%
Implementation Science Framework
9%
Opioids
8%
Lung Damage
8%
Low-income
8%
Incentive Spirometry
8%
Respiratory Complications
8%
New York
8%
Adherence to Guidelines
8%
Diseased Population
8%
Systems Intervention
6%
Implementation Trial
6%
Nursing and Health Professions
Sickle Cell Anemia
75%
Pilot Study
75%
Acute Chest Syndrome
75%
Morbidity
75%
Pediatrics
33%
Implementation Science
24%
Health Care Quality
16%
8 Difluoromethoxy 1 Ethyl 6 Fluoro 1,4 Dihydro 7 [4 (2 Methoxyphenyl) 1 Piperazinyl] 4 Oxo 3 Quinolinecarboxylic Acid
16%
Health Care Personnel
16%
Health Services Research Methods
8%
Health Services Research
8%
Hemolytic Anemia
8%
Disease Management
8%
Patient with Sickle Cell Disease
8%
Hematologist
8%
Healthcare System
8%
Electronic Health Record
8%
Bioinformatics
8%
Education
8%
Epidemiology
8%
Syndrome
5%
Clinical Decision Support System
5%
Medicine and Dentistry
Sickle-Cell Disease
100%
Acute Chest Syndrome
100%
Morbidity
100%
Pediatrics
39%
Implementation Science
24%
8 Difluoromethoxy 1 Ethyl 6 Fluoro 1,4 Dihydro 7 [4 (2 Methoxyphenyl) 1 Piperazinyl] 4 Oxo 3 Quinolinecarboxylic Acid
16%
Health Care Personnel
16%
Clinical Decision Support System
11%
Lifespan
8%
Health Care
8%
Patient with Sickle Cell Disease
8%
Hemolytic Anemia
8%
Cohort Effect
8%
Disease Management
8%
Electronic Health Record
8%
Health Services Research
8%
Health Services Research Methods
8%
Education
8%
Spirometry
6%